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Response Time of Broiler Chickens to Cimaterol: 
Meat Tenderness, Muscle Composition, Fiber Size, 
and Carcass Characteristic~l~~ 
B. L. Gwartney, S. J. Jones, and C. R. Calkins 
Department of Animal Science, University of Nebraska, Lincoln 68583-0908 
ABSTRACT: The response time to cimaterol 
(CIM), a P-adrenergic agonist, by broiler chickens 
for carcass characteristics, muscle composition, 
muscle fiber size, catheptic enzyme activity, and 
tenderness was determined. Two trials were con- 
ducted in which chickens were fed a control diet 
(CON) containing 0 ppm of CIM or a diet contain- 
ing 1 ppm of CIM. Trial 1 consisted of 55, 
31-d-old broiler chickens individually fed for up to 
48 h. At 0, 6, 12, 18, 24, and 48 h, five CON and five 
CIM-fed chickens were killed. Trial 2 consisted of 
160, 33-d-old broiler chickens group-fed for up to 14 
d. At 2,4,6,  8, 10, 12, and 14 d, 10 CON and 10 CIM- 
fed chickens were killed. The breast muscle (BM) 
and leg muscle (LM) weight, cathepsin B and L 
activities, DNA, RNA, and protein concentration, 
and BM shear force value (SFV) were measured in 
both trials. Thigh muscle (TM) SFV were measured 
in Trial 2 only. Fiber size of BM was measured (five 
birds per treatment) at d 2, 6, 10, and 14. In Trial 1, 
BM weight and SFV were lower in CIM-fed birds 
at  6 h (P < ,051. In Trial 2 BM SFV were higher at  d 
8 (P = ,061 and d 10 (P c .05) in CIM-fed chickens. 
The SFV of CIM-fed chickens were higher at d 4,  8, 
lo, 12, and 14 (P < .051. The BM of CIM-fed 
chickens had a higher protein:DNA ratio (P < .05) 
at  d 6 through 14, whereas LM of CIM-fed chickens 
had a higher protein:DNA ratio a t  d 8, 10, and 14. 
Fiber size of the BM in CIM-fed chickens tended to 
be larger at  d 10 (P = .I31 and at d 14 (P = ,171. 
Total BM weight and BM as a percentage of final 
body weight (FBW) was higher at  d 10 and 14 (P < 
.01) in CIM-fed chickens. Total LM weight and LM 
as a percentage of FBW was higher at d 14 ( P  < 
.01) in CIM-fed chickens. In the BM of CIM-fed 
chickens, protein:DNA ratio increased by d 6, SFV 
by d 8, muscle fiber size by d 10, and BM weight 
and BM as a percentage of FBW by d 10. The TM 
or LM of CIM-fed chickens showed increases in 
SFV by d 4, protein:DNA ratio by d 8, and LM 
weight and LM as a percentage of FBW by d 14. 
Response times to treatment with CIM differed for 
the various traits measured (i.e., meat tenderness, 
muscle composition, fiber size, or carcass charac- 
teristics). 
Key Words: Cimaterol, Cathepsins, DNA, RNA, Protein, Meat Characteristics 
Introduction 
The use of P-adrenergic agonists provides an 
excellent model for studying changes in muscle 
growth. Recent studies have dealt with the effect 
of cimaterol (CIM), a P-adrenergic agonist, on 
various carcass traits of meat animals. It is 
established that CIM decreases fat accumulation 
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and increases protein accretion in the muscle of 
many animal species, including sheep (Baker et 
al., 19841, poultry (Dalrymple et al., 19841, and 
swine (Jones et al., 1985). It also decreases tender- 
ness in the meat of various species (Jones et al., 
1985; Allen et al., 1986; Hamby et al., 1986; Morgan 
et al., 1989). 
The mechanisms that are involved in making 
meat of CIM-treated animals less tender are 
unknown. Some researchers have investigated 
catheptic enzyme activities in CIM-treated 
animals with the hypothesis that enzyme activities 
are lowered by CIM and this reduces tenderness 
(Forsberg et al., 1987; Kretchmar et al., 1988). This 
would support the idea that CIM acts to increase 
muscle accretion via a reduction in muscle degra- 
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dation (Young et al., 1990). Morgan et al., (1989) 
found that cathepsin B and L activities were lower 
in CIM-treated chickens and were negatively 
correlated with shear force value (SFV). 
Muscle hypertrophy in CIM-treated animals 
may be involved with the observed tenderness 
reduction. Maltin et al. (1986) observed an  increase 
in the area of type I1 fiber of rats treated with 
clenbuterol. Kim et al. (1987) and Beermann et al. 
(1987) found that CIM-treated sheep had increased 
cross-sectional areas in type I1 fibers. Both studies 
demonstrated that DNA concentration was lower 
in CIM-treated lambs. This suggests that muscle 
fibers may become more densely packed due to 
muscle fiber hypertrophy, which may cause a 
toughening effect. 
In most studies CIM has been fed for a period of 
6 to 12 wk before muscle sampling. The objective 
of this study was to investigate the response time 
of carcass variables to CIM by broiler chickens 
during hours (0 to 48 h) or days (0 to 14 dl after 
initiation of treatment. 
Experimental Procedure 
In Trial 1, 55 broiler chickens (31 d old) were 
randomly assigned to individual pens and given 
ad libitum access to either a control diet (CON) 
containing 0 ppm of CIM or a diet containing 1 
ppm of CIM. In Trial 2, 160 broiler chickens (33 d 
old) were divided equally into two electrically 
heated battery brooders (Petersime Incubator, 
Gettysburg, OH). Within each battery, chickens 
received the CON diet (n = 80) or the CIM diet (n 
= 80). Eight chickens were housed in each pen 
with 10 pens per battery. All chickens had free 
access to tap water and had ad libitum access to a 
20% CP growing diet (90% DM, 3,131 kcal of ME/ 
kg) consisting of 64 3% grain sorghum, 25.3% 
soybean meal (47.5941 CP), 5.O0/0 animal fat, and a 
vitamin and mineral supplement. All chickens 
were withheld from feed for 3 h before starting the 
trial to ensure immediate ingestion of feed. 
In Trial 1 five chickens were killed at  0 h (before 
feeding) to obtain baseline values for carcass 
variables, and additional chickens (five CON and 
five CIM) were killed at  6, 12, 18, 24, and 48 h. In 
Trial 2 10 CON and 10 CIM-fed chickens were 
killed a t  time 0 for use as baseline values, and 
additional chickens (10 CON and 10 CIMl were 
killed at d 2, 4, 6, 8, 10, 12, and 14. 
Breast muscle weight (BM) and leg muscle 
weight (LM) were recorded a t  each kill period. The 
BM consisted of the pectoralis major; LM consis- 
ted of the gastrocnemius and peroneus longus. In 
Trial 2 the thigh muscle (TM; consisting of the 
biceps femoris, semitendinosus, semimembrano- 
sus, and tensor facia latae) were removed for SFV 
analysis. 
Cathepsin B and L activities were measured in 
BM and LM samples. Total cathepsin B and L 
activities were determined in samples prepared 
using the procedures of Moeller et al. (1976) with 
slight modifications. One BM and both LM were 
removed immediately postmortem, frozen in liquid 
nitrogen, and stored at -70°C until further analy- 
sis for each trial. Ten grams of muscle (BM or LM) 
was homogenized in 50 mL of ice-cold .25 M 
sucrose containing .02 M KC1. The homogenate 
was filtered through two layers of cheesecloth and 
adjusted to a pH of 7.3 with 1 N KOH. The filtrate 
was centrifuged at 6,000 x g for 6 min, and the 
supernatant was decanted and saved. The pellet 
was resuspended in 25 mL of the sucrose-KC1 
solution and recentrifuged. Supernatants were 
combined and measured for protein content using 
the biuret method (Gornall et a]., 1949). Samples 
were diluted to attain similar protein levels (.3 mg/ 
mL) for the cathepsin assay. Total and specific 
cathepsin B and L activities were measured by the 
techniques of Barrett (1980) with modifications. 
The substrate N-carbobenzoxy(CBZ)-L-phenyl- 
alanine-L-arginine-4-methyl-7-amino hydrochloride 
was used at  an  assay concentration of 1 mM. The 
buffer system was a .704 M potassium phosphate, 
.096 M sodium phosphate at  pH 5.8. This substrate 
is hydrolyzed by both cathepsins B and L (Barrett 
and Kirschke, 1981). 
Muscle protein, DNA, and RNA contents were 
determined in the BM and LM of chickens in Trial 
2. Protein content of whole muscles was deter- 
mined using the biuret method of Gornall et al. 
(1949). DNA was analyzed using the method of 
Labraca and Paigen (1980). RNA was separated 
using the method of Shiboko et al. (19671 and 
quantified using the procedure of Lin and Schjeide 
(1969). 
Muscle fiber size of the BM was determined in 
five chickens per treatment at  d 2, 6, 10, and 14. 
Frozen muscle samples were cryosectioned and 
fixed on a glass slide. Slices of muscle were 
approximately 8 p m  in thickness. Sample prepara- 
tion and staining was accomplished using the 
procedures of Guth and Samaha (1970). Area of the 
muscle was determined using the Bio Quant 
software program (R & M Biometrics, Nashville, 
TN). 
Shear force values were determined on cooked 
BM (both trials) and on TM in Trial 2 that had 
remained on the carcass at  room temperature for 
2 h postmortem. The EM and TM were excised and 
placed in a 4°C cooler for 24 h, to allow any 
postmortem enzymatic tenderization to occur, 
frozen, and stored at -70°C. Samples were re- 
moved from the freezer, allowed to temper a t  4°C 
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Table 1. The effect of cimaterol on breast and leg muscle weights, feed consumption, 
cathepsin B and L activity, and shear force values during 48 hours (Trial 1) 
@ 
Cathepsin B and L activitya 
Feed Shear value 
Breast wt, gb Leg wt, gb consumed, g Breast Leg of breast, kgC 
Time on 
feed, h  CON^ CIMe CON CIM CON CIM CON CIM CON CIM CON CIM 
0 25.85 N / A ~  20.04 N/A N/A N/A 760.4 N/A 279 N/A 1.30 N/A 
6 28.14* 23.59 18.70 19.27 47.02 40.76 970.85 897.3 375.88 283.02 2.28* 1.05 
12 27.05 25.41 20.33 18.91 62.34 57.42 827.97 793.12 275.08 272.41 .82 .76 
18 25.98 26.41 19.01 19.63 86.64 76.52 746.72 849.12 304.39 171.53 1.18 .6 1 
24 24.61 24.98 20.05 18.15 107.28 95.36 777.26 702.04 197.65 217.74 .95 1.14 
48 28.81 31.53 22.55 21.74 181.14 174.26 711.74 918.31 308.17 388.29 1.87 1.18 
SEMg .5 1 .79 .38 .50 9.87 .79 43.79 51.96 28.64 26.23 .15 .09 
&Total activity, nanomoles~milligram-l .minutep1 of product released. 
b ~ r e a s t  muscle consisted of the pectoralis major and leg muscle consisted of the gastrocnemius and peroneous longus. 
'Shear values are presented as kilograms of peak force to shear a .5-cm x 1-cm x 3-cm sample of breast muscle. 
d~~~ = birds fed 0 ppm of cimaterol in diet (n = 5). 
eCIM = birds fed 1 ppm of cimaterol in diet (n = 5). 
f ~ a t a  not available. 
gPooled SEM for each feeding treatment. 
*Significant difference P < ,051 within time on feed for specific variable. 
for approximately 14 h, double-wrapped in alumi- 
num foil, and heated to an internal temperature of 
82°C in a 177°C electric oven. Temperature was 
monitored using small-diameter, copper-constan- 
tan thermocouples attached to a digital thermome- 
ter (Omega Engineering, Stamford, CTI. Samples 
were allowed to cool at  room temperature for 2 h 
before testing. In Trial 1, a 3-cm x 3-cm x .5-cm 
sample was removed from the thick, anterior 
portion of the BM. Three .5-cm x 1-cm x 
3-cm slices were obtained from this sample with 
fiber direction parallel to the 3-cm length. Shear 
force values were determined using an  Instron 
Universal Testing Machine (Instron, Canton, MA) 
with a Warner-Bratzler shear attachment. In Trial 
2, a 3-cm x 3-cm x 1-cm sample was removed from 
the BM and TM. Three I-cm x I-cm x 3-cm slices 
were obtained from this with fiber direction 
parallel to the 3-cm length. Peak SFV are pre- 
sented as the peak load (in kilograms) required to 
shear the muscle sample. Shear values were 
obtained using the Instron machine and a 
500-kg load cell with a full scale load of 1, a preset 
crosshead speed of 250 mm/min, and a propor- 
tional chart speed ratio of 2:l (millimeters/minute). 
Statistical analyses of data collected in Trial 1 
involved in a n  analysis of variance for a com- 
pletely randomized design with individual chick- 
ens as the sampling unit (Steel and Torrie, 19801. 
Trial 2 consisted of a 2 x 8 factorial arrangement of 
treatments with battery as replication. Treatment 
means, standard deviations, and analysis of vari- 
ance were calculated using SAS (1985). A series of 
orthogonal contrasts was used to determine treat- 
ment differences within kill periods for each 
variable. 
Results and Discussion 
No differences (P > ,051 were observed in Trial 1 
for any of the variables measured (Table 11, with 
the exception that SFV and BM weight at  6 h were 
lower in CIM-fed chickens than in CON chickens 
(P < .05). Chickens were withheld from feed for 3 h 
before starting the feeding trials, which possibly 
put them in a catabolic state. Feed consumption of 
CIM-treated chickens is lower than that of con- 
trols for up to 2 d (Gwartney et al., 19911. 
In Trial 2, BM SFV were higher in CIM-fed 
chickens on d 8 (P = .06) and on d 10 ( P  < ,051 
(Table 2). Thigh muscle SFV were higher (P c .051 
in CIM-fed chickens at  d 4, 8, 10, 12, and 14 (Table 
21. Morgan et al. (19891 and Gwartney et al. (19911 
observed higher SFV in BM of CIM-fed chickens 
after 21 d of feeding CIM. Decreases in meat 
tenderness have been observed in pork (Jones et 
al., 19851, lambs (Hamby et al., 19861, and cattle 
(Allen et al., 1986) after feeding a P-adrenergic 
agonist. The unique finding in this study was that 
tenderness differences were observed after as little 
as 4 d of treatment. Early changes in tenderness 
may occur in other species, but researchers have 
not identified them. Perhaps tenderness differ- 
ences occur in broiler chickens earlier because 
chickens respond faster than other animals due to 
their rapid growth rate. 
Thigh muscle was used for SFV in this study to 
relate CIM-induced tenderness differences in mus- 
cle to different populations of type I and type I1 
fibers. Differences in SFV were observed earlier in 
LM than in BM, which may be due to response 
time of muscle fiber types to CIM. Watson-Wright 
and Wilkinson (1986) reported that skeletal muscle 
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Table 2. The effects of cimaterol on breast and thigh muscle shear values (SFV) 
and breast and leg cathepsin B and L activities during 14 days (Trial 2) 
Breast cathepsin Leg cathepsin B 
Breasta SFV Thigha SFV B and L activity and L activity 
Time on 
feed, d  CON^ CIMC CON CIM CON CIM CON CIM 
0 1.41d 1.83 1.49 1.33 1 ,237~ 1,099 296 325 
2 2.10 2.37 1.37 1.17 1,621 1,685 330 364 
4 3.28 3.54 1.61* 2.10 1,724 1,472 352 390 
6 3.03 3.62 1.59 1.77 1,476 1,207 315 37 1 
8 2.19" 3.61 1.88* 2.11 1,172 1,026 418 438 
10 2.64* 5.14 1.82* 2.00 1,185 925 404 453 
12 1.70 2.71 1.57* 1.98 1,388 1,346 394 439 
14 2.29 3.43 1.70* 1.99 1,347 1,25 1 329 387 
S E M ~  .13 .16 .04 .08 60 58 13 14 
aBreast consisted of the pectoralis major and leg consisted of the combined gastrocnemius and 
peroneous longus. 
b~~~ = birds fed 0 ppm of cimaterol in diet. 
CCIM - birds fed 1 ppm of cimaterol in diet. 
d ~ h e a r  values are presented as  kilograms of peak force to shear a 1-cm x 1-cm x 3-cm sample of 
breast muscle. 
eTotal activity, nanomoles milligram-' .minute-' of product released. 
f~ooled SEM for each feeding treatment. 
*Significant difference (P < .05) within time on feed for specific variable. 
possesses receptors of the P-2 subclass, but that 
receptor density is a function of muscle type. Type 
I1 fibers seem to have a low P-receptor density, 
whereas type I fibers contain a high P receptor 
density; therefore the slower response in BM to 
CIM treatment may be due to the lower proportion 
of P-receptors present. 
Differences among SFV between muscles were 
not analyzed; however, TM tended to be lower 
than BM (Table 2). Muscles in the leg of chickens 
have more connective tissue because of the 
perimysium that surrounds the individual mus- 
cles. However, increased fat levels associated with 
LM compared to BM (Morgan et al. 1989; Gwart- 
ney et al., 19911 may reduce SFV. 
No differences between treatments (P > .05) 
were found in total cathepsin B and L activities for 
either BM or LM in Trial 2 [Table 2). However, 
mean activity for BM was lower at  all kill periods 
in CIM-fed chickens except for d 2, which may 
have been higher because (as mentioned previ- 
ously for Trial 11 chickens may have been in a 
catabolic state due to reduced feed consumption. 
Cimaterol-fed chickens began to show the effects 
Table 3. The effects of cimaterol on breast and leg muscle weights 
and as a percentage of final body weight during 14 days (Trial 2). 
Breasta wt, g Lega wt, g Breast, % Leg, O/O 
Time on 
feed, d  CON^ CIMC CON CIM CON CIM CON CIM 
0 64.1 71.4 53.6 59.9 6.57 6.85 5.53 5.79 
2 78.6 78.0 61.7 63.6 6.80 6.61 5.32 5.37 
4 88.6 95.4 67.0 67.6 7.12 7.42 5.41 5.28 
6 101.0 101.9 81.2 89.9 7.09 7.35 5.67 5.90 
8 106.4 109.7 82.1 89.9 7.31 7.30 5.67 5.90 
10 119.6** 135.0 98.3 103.5 6.99** 8.12 5.75 6.16 
12 146.8 149.4 112.5 117.0 7.95 8.10 6.09 6.35 
14 139.8** 163.9 108.9** 132.4 7.36** 8.07 5.75** 6.53 
S E M ~  3.68 4.16 2.79 3.22 ,068 ,088 9.04 8.06 
&Breast consisted of the pectoralis major and leg consisted of the combined gastrocnemius and 
peroneous longus. 
b~~~ = birds fed 0 ppm of cimaterol in diet. 
CCIM = birds fed 1 pprn of cimaterol in diet. 
d~ooled SEM for each feeding treatment. 
*Significant difference (P < ,051 within time on feed for specific variable. 
**Signif~cant difference IP < ,011 within time on feed for specific variable. 
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Table 4. The effect of cimaterol on breasta muscle protein, RNA, and DNA (Trial 2) 
Protein, mg/g RNA, mg/g DNA, mg/g Protein:RNA Protein:DNA RNA:DNA 
Time on 
feed, d  CON^ CIMC CON CIM CON CIM CON CIM CON CIM CON CIM 
- - 
&Breast muscle consisted of the pectoralis major. 
b~~~ = birds fed 0 ppm of cimaterol in diet 
CCIM = birds fed 1 ppm of cimaterol in diet 
d ~ o o l e d  SEM for each feeding treatment. 
*Significant difference ( P  < .05) within time on  feed for specific variable 
of the P-adrenergic agonist after they recovered 
from the catabolic period, which may have 
delayed other CIM-related changes. 
Total BM weight and BM as a percentage of 
final BW were elevated at  d 10 and 14 (P < .01) in 
CIM-fed chickens (Table 3). This finding is in 
agreement with the results of Morgan et al. (19891, 
who found higher BM percentage after only 17 d of 
feeding CIM. Leg muscle weight and LM percent- 
ages were higher a t  d 14 (P c .01) in CIM-fed 
chickens. The increase in percentage of LM and 
BM indicates that there was an  improvement in 
leanness of CIM-fed chickens. 
In Trial 2 the protein:RNA ratio was lower (P < 
.05) in the BM only at  d 8 and in the LM at  d 2 to 8 
of CIM-fed chickens (Tables 4 and 51, indicating 
that RNA increased in relation to protein. The 
RNA:DNA ratio was higher (P < .05) in the BM at  
d 8 and 10, and at d 4 and 8 in the LM of CIM-fed 
chickens. The increase in RNA:DNA ratio indi- 
cates an increase in protein synthetic capacity per 
unit DNA in CIM-fed chickens. Neither protein: 
RNA nor RNA:DNA ratio differences were main- 
tained throughout the study. Beermann et al. 
(1987) reported that RNA:DNA ratio was higher in 
CIM-fed lambs at  7 wk of feeding but was similar 
at  12 wk. These data reveal that CIM may alter 
the protein synthetic capacity of the muscle early 
in treatment, but the differences are attenuated 
with continued treatment. McElligott et al. (1989) 
observed that the growth response to clenbuterol 
in rats is attenuated after 2 wk of continuous 
treatment. 
The protein:DNA ratio was higher (P 4 .05) and 
DNA per unit amount was lower ( P  .05) in the 
BM of CIM-fed chickens from d 6 to d 14 and in LM 
on d 8, 10, and 14 (Tables 4 and 5). Kim et al. (1987) 
and Beermann et al. (1987) identified similar 
trends. This indicates that P-agonists increase 
muscle size by hypertrophy, which may occur by 
Table 5. The effect of cimaterol on lega muscle protein, RNA, and DNA (Trial 2) 
- - - - 
Protein, mg/g RNA, mg/g DNA, mg/g Prote1n:RNA Protein DNA RNA:DNA 
Time on 
feed, d  CON^ CIMC CON CIM CON CIM CON CIM CON CIM CON CIM 
&Leg muscles consisted of the  gastrocnemius and peroneous longus. 
b~~~ = birds fed 0 ppm of cimaterol in the diet. 
CCIM = birds fed 1 ppm of cimaterol in the diet. 
d ~ o o l e d  SEM for each feeding treatment. 
*Significant difference (P < ,051 within time on feed for specific variable. 
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Figure 1. Fiber area of the pectoralis major muscle of 
cimaterol-fed and control broiler chickens (n = 5). 
decreasing the rate of the muscle protein degrada- 
tion. Changes in degradative activity in the muscle 
may cause decreased tenderness postmortem, as 
was observed in this study. However, differences 
in the cathepsin B and L activities were not 
demonstrated, which may indicate that other 
degradative systems, such as  the calpain enzymes, 
may be responsible. 
Muscle fiber size (Figure 1) in the BM tended to 
be larger in CIM-fed chickens than in CON 
chickens at  d 10 (P = .13) and d 14 (P = .17). These 
differences were not significant, possibly because 
of the limited number (n = 5 )  of samples. These 
data were similar to those reported in rats (Maltin 
et al., 1986) and lambs (Beermann et al., 1987; Kim 
et al., 1987). Differences in both of the studies with 
lambs were primarily in type I1 fibers. The BM of 
chickens is primarily type I1 fibers, so it would be 
expected to be affected by CIM. The changes in 
fiber size tend to support the protein:DNA ratio 
data that muscle hypertrophy causes a change in 
muscle mass. Because tenderness differences were 
observed at an earlier date, it can be concluded 
that tenderness differences are not the manifesta- 
tion of large fibers. 
Implications 
Chickens fed cimaterol begin to show tender- 
ness differences as  early as 4 d in thigh muscle 
and 8 d in breast muscle. Muscle fiber type may 
influence the ability of cimaterol to alter their 
compositional makeup. The protein:DNA ratio 
increases, at  which time muscle weight begins to 
increase, suggesting that cimaterol has the ability 
to allow more protein per given DNA unit. This 
may be the result of decreased degradation rates 
of skeletal protein when cimaterol is fed. 
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